GC36356
Ixazomib citrate
Also known as 2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid
Ixazomib citrate (MLN9708) is a reversible inhibitor of the chymotrypsin-like proteolytic β5 site of the 20S proteasome with an IC50 of 3·4 nM and a Ki of 0·93 nM
ChemicalCAS1239908-20-3MW517.12FormulaC20H23BCl2N2O9
- CAS number
- 1239908-20-3
- Molecular weight
- 517.12
- Formula
- C20H23BCl2N2O9
- Solubility
- DMSO： ≥ 100 mg/mL (193·38 mM)
- InChIKey
- MBOMYENWWXQSNW-AWEZNQCLSA-N
- Catalogue number
- GC36356
- Brand
- GLPBIO
Computed properties PubChem CID 56844015 · TPSA 168 Ų · H-bond donors 4 · H-bond acceptors 9
- TPSA
- 168 Ų
- H-bond donors
- 4
- H-bond acceptors
- 9
- Rotatable bonds
- 11
- Heavy atoms
- 34
SMILES B1(OC(=O)C(O1)(CC(=O)O)CC(=O)O)[C@H](CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl
Computed descriptors from PubChem (CID 56844015), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il